SNHG6 and metabolic dysfunction-associated steatotic liver disease: The researchers observed a dynamic interplay between cholesterol and the SNHG6, a putative cholesterol effector, and their engagement in a self-amplified cycle that accelerated the NAFLD-related HCC development.